logo

For the Inventor, By the Inventor

North East, MD, United States of America

Mark Gordon Mortenson

This inventor holds 33 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 6 EPO patents. Top assignees: Grintellectual Reserve, LLC, Lanxide Technology Company, LP, Clene Nanomedicine, Inc.. Active years: 1989-2025.

USPTO Granted Patents = 33 

% Patents Active = 72.7


 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 144(Granted Patents)


Company Filing History:

goldMedal14 out of 20 
 
Grintellectual Reserve, LLC
 patents
silverMedal8 out of 312 
 
Lanxide Technology Company, LP
 patents
bronzeMedal5 out of 5 
 
Clene Nanomedicine, Inc.
 patents
4. 1 out of 1 
 
Ciene Nanomedicine, Inc.
 patent
5. 1 out of 1 
 
Clene Nanomedicine, Inc, a Nevada Corporation
 patent
6. 1 out of 1 
 
Gr Intellectual Reserve, LLC, a Nevada LLC
 patent
7. 3 out of 834,307 
Other
 patents

Years Active: 1989-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nanoparticles
Nanocrystals
Electrochemical Manufacturing
Crystal Growth Control
Fuel Cell Optimization
Data Storage Devices
Solar Cells
Metal Matrix Composites
Colloids
Chemical Reactions
Continuous Liquid Treatment
Batch Manufacturing Methods
33 patents (USPTO):Explore Patents
1. 12415218 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2025-09-16),
2. 11007573 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2021-05-18),
3. 11000042 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2021-05-11),
4. 10980832 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2021-04-20),
5. 10449217 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2019-10-22),
6. 10441608 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2019-10-15),
7. 10092007 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2018-10-09),
8. 10035192 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g.,nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2018-07-31),
9. 9743672 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2017-08-29),
10. 9603870 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2017-03-28),
11. 9387452 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2016-07-12),
12. 9387225 - Gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same (2016-07-12),
13. 9067263 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2015-06-30),
14. 8734535 - Methods for controlling crystal growth, crystallization, structures and phases in materials and systems (2014-05-27),
15. 8617360 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2013-12-31),

Title: Innovator Spotlight: Mark Gordon Mortenson

Introduction:

Mark Gordon Mortenson is a prolific inventor based in North East, MD, with an impressive track record of 32 patents. His innovative work has significantly contributed to the field of nanoparticle manufacturing and liquid treatment processes.

Latest Patents:

One of Mortenson's recent patents involves continuous, semicontinuous, and batch methods for treating liquids and manufacturing nanoparticles in liquids. This invention introduces novel techniques and devices for creating nanoparticles, microparticles, and nanoparticle/liquid solutions. By utilizing adjustable plasmas and electrochemical processing techniques, Mortenson's process results in the formation of unique nanoparticles with diverse compositions and properties.

Career Highlights:

Mortenson has made substantial contributions to companies like Grintellectual Reserve, LLC, and Lanxide Technology Company, LP. His forward-thinking approaches to innovation have propelled these organizations towards cutting-edge advancements in the field.

Collaborations:

Throughout his career, Mortenson has collaborated with esteemed professionals such as David Andrew Bryce and David Kyle Pierce. These collaborations have fostered a culture of innovation and knowledge-sharing, leading to groundbreaking inventions and patents in the industry.

Conclusion:

Mark Gordon Mortenson's dedication to pushing the boundaries of nanoparticle manufacturing and liquid treatment processes is evident in his extensive patent portfolio. His collaborative spirit and inventive thinking continue to inspire new advancements in the field, solidifying his legacy as a trailblazer in innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…